William Thies

TL;DR: This report provides information to increase understanding of the public health impact of Alzheimer's disease (AD), including incidence and prevalence, mortality rates, health expenditures and costs of care, and effect on caregivers and society in general.

TL;DR: This report provides information to increase understanding of the public health impact of Alzheimer's disease and explores issues that arise when people with AD and other dementias live alone.

TL;DR: In response to concerns raised by the Food and Drug Administration, the Alzheimer's Association Research Roundtable convened a working group to review the publicly available trial data, attempts at developing animalmodels, and theliterature ontologyonthenatural historyandpathologyofrelated conditions.

TL;DR: A set of specific appropriate use criteria (AUC) were agreed on that define the types of patients and clinical circumstances in which amyloid PET could be used, and both appropriate and inappropriate uses were considered and formulated, and are reported and discussed here.

TL;DR: Widespread implementation of this algorithm could be the first step in reducing the prevalence of missed or delayed dementia diagnosis, thus allowing for better healthcare management and more favorable outcomes for affected patients and their families and caregivers.